HK1162145A1 - Aqueous clear solutions of fluocinolone acetonide for treatment of otic inflammation - Google Patents
Aqueous clear solutions of fluocinolone acetonide for treatment of otic inflammationInfo
- Publication number
- HK1162145A1 HK1162145A1 HK12102610.2A HK12102610A HK1162145A1 HK 1162145 A1 HK1162145 A1 HK 1162145A1 HK 12102610 A HK12102610 A HK 12102610A HK 1162145 A1 HK1162145 A1 HK 1162145A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- treatment
- fluocinolone acetonide
- clear solutions
- aqueous clear
- otic inflammation
- Prior art date
Links
- 206010061218 Inflammation Diseases 0.000 title 1
- 229960001347 fluocinolone acetonide Drugs 0.000 title 1
- FEBLZLNTKCEFIT-VSXGLTOVSA-N fluocinolone acetonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O FEBLZLNTKCEFIT-VSXGLTOVSA-N 0.000 title 1
- 230000004054 inflammatory process Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10155005A EP2366408B1 (en) | 2010-03-01 | 2010-03-01 | Aqueous clear solutions of fluocinolone acetonide for treatment of otic inflammation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1162145A1 true HK1162145A1 (en) | 2012-08-24 |
Family
ID=42668238
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK12102610.2A HK1162145A1 (en) | 2010-03-01 | 2012-03-14 | Aqueous clear solutions of fluocinolone acetonide for treatment of otic inflammation |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8932610B2 (ru) |
| EP (1) | EP2366408B1 (ru) |
| JP (1) | JP5744922B2 (ru) |
| KR (1) | KR101777157B1 (ru) |
| CN (1) | CN102811741B (ru) |
| AR (1) | AR080368A1 (ru) |
| AU (1) | AU2011223095B2 (ru) |
| BR (1) | BR112012021638B1 (ru) |
| CA (1) | CA2790652C (ru) |
| DK (1) | DK2366408T3 (ru) |
| ES (1) | ES2391721T3 (ru) |
| HK (1) | HK1162145A1 (ru) |
| MX (1) | MX2012010009A (ru) |
| PL (1) | PL2366408T3 (ru) |
| RU (1) | RU2549465C2 (ru) |
| WO (1) | WO2011107436A2 (ru) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2604413C1 (ru) * | 2015-06-17 | 2016-12-10 | Марина Николаевна Вольгова | Способ лечения хронического аллергического наружного отита |
| WO2016208742A1 (ja) * | 2015-06-25 | 2016-12-29 | 参天製薬株式会社 | 注射剤 |
| JP6255134B1 (ja) * | 2016-11-02 | 2017-12-27 | ヴェローチェ・バイオファーマ・エルエルシー | 耳炎の治療のための組成物および方法 |
| KR102094228B1 (ko) | 2017-12-18 | 2020-03-27 | 경희대학교 산학협력단 | 운카리아 린초필라 추출물을 유효성분으로 포함하는 난청의 예방 또는 치료용 조성물 |
| KR102075694B1 (ko) | 2017-12-18 | 2020-02-10 | 경희대학교 산학협력단 | 시지지움 큐미니 추출물을 유효성분으로 포함하는 난청의 예방 또는 치료용 조성물 |
| KR102007096B1 (ko) | 2017-12-18 | 2019-08-02 | 경희대학교 산학협력단 | 비스쿰 오발리포리움 추출물을 유효성분으로 포함하는 난청의 예방 또는 치료용 조성물 |
| KR102030123B1 (ko) | 2018-05-31 | 2019-10-08 | 경희대학교 산학협력단 | 난청의 예방 또는 치료용 조성물 |
| KR102131044B1 (ko) | 2018-05-31 | 2020-07-08 | 경희대학교 산학협력단 | 난청의 예방 또는 치료용 조성물 |
| KR102035845B1 (ko) | 2018-05-31 | 2019-10-23 | 경희대학교 산학협력단 | 난청의 예방 또는 치료용 조성물 |
| CN109260152A (zh) * | 2018-11-13 | 2019-01-25 | 禹州市中医院 | 一种盐酸洛美沙星滴耳液 |
| CN112022805A (zh) * | 2020-10-20 | 2020-12-04 | 内蒙古盛唐国际蒙医药研究院有限公司 | 一种高稳定性复方醋酸氟轻松酊及其制备方法 |
| KR20220091176A (ko) | 2020-12-23 | 2022-06-30 | (주)인비보텍 | 난청의 예방 또는 치료용 조성물 |
| KR20220091177A (ko) | 2020-12-23 | 2022-06-30 | (주)인비보텍 | 난청의 예방 또는 치료용 조성물 |
| US11672798B2 (en) | 2021-06-03 | 2023-06-13 | Laboratorios Salvat, S.A. | Ciprofloxacin ophthalmic topical composition for treating ocular disease |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1013180A (en) * | 1962-10-30 | 1965-12-15 | Ici Ltd | Steroid compositions |
| US3326808A (en) * | 1965-08-25 | 1967-06-20 | Pfizer & Co C | Antiseptic detergent composition |
| GB1133800A (en) * | 1966-11-10 | 1968-11-20 | Ici Ltd | Pharmaceutical compositions |
| GB1411432A (en) * | 1972-01-10 | 1975-10-22 | Medisan Ab | Skin treating compositions |
| AU7776275A (en) | 1974-04-11 | 1976-08-05 | Warner Lambert Co | Production of base for topical steroids |
| US4013792A (en) * | 1974-04-11 | 1977-03-22 | Warner-Lambert Company | Process for the production of base for topical steroids |
| US3934013A (en) | 1975-02-21 | 1976-01-20 | Syntex (U.S.A.) Inc. | Pharmaceutical composition |
| DE3704907A1 (de) | 1987-02-17 | 1988-08-25 | Bayer Ag | Topisch anwendbare zubereitungen von gyrase-inhibitoren in kombination mit kortikosteroiden |
| AU4201189A (en) | 1988-08-26 | 1990-03-23 | Alcon Laboratories, Inc. | Combination of quinolone antibiotics and steroids for topical ophthalmic use |
| US5897858A (en) * | 1994-02-03 | 1999-04-27 | Schering-Plough Healthcare Products, Inc. | Nasal spray compositions exhibiting increased retention in the nasal cavity |
| PT782448E (pt) | 1995-06-06 | 2002-07-31 | Bayer Ag | Formulacoes oticas antibacterianas nao ototoxicas nao sensibilizantes nao irritantes |
| ES2106680B1 (es) | 1995-08-03 | 1998-07-01 | Vita Invest Sa | Composiciones acuosas conteniendo ciprofloxacino y utilizacion y procedimiento correspondientes. |
| US6274634B1 (en) * | 1997-05-14 | 2001-08-14 | Senju Pharmaceutical Co., Ltd. | Aqueous suspension preparations with excellent redispersibility |
| US5997518A (en) * | 1998-01-14 | 1999-12-07 | Laibovitz; Robert A. | Apparatus and method for delivery of small volumes of liquid |
| US5990100A (en) * | 1998-03-24 | 1999-11-23 | Panda Pharmaceuticals, L.L.C. | Composition and method for treatment of psoriasis |
| JP2002513750A (ja) | 1998-05-07 | 2002-05-14 | エラン コーポレーシヨン ピーエルシー | 溶媒／助溶剤を含まないマイクロエマルジョン及びエマルジョンプレ濃縮物のドラッグデリバリーシステム |
| US6241969B1 (en) * | 1998-06-26 | 2001-06-05 | Elan Corporation Plc | Aqueous compositions containing corticosteroids for nasal and pulmonary delivery |
| TR200200737T2 (tr) | 1999-09-24 | 2002-08-21 | Alcon, Inc. | Siproflaksasin ve deksametazon içeren lokal süspansiyon formülasyonları |
| US6235722B1 (en) * | 1999-09-24 | 2001-05-22 | Balakrishnan Jayapathy | Pharmacological preparation |
| US20010049366A1 (en) * | 2000-02-09 | 2001-12-06 | Alcon Universal Ltd. | Topical solution formulations containing an antibiotic and a corticosteroid |
| US20030195179A1 (en) * | 2000-08-25 | 2003-10-16 | Shirou Sawa | Aqueous suspension preparations |
| US20040097592A1 (en) * | 2000-09-13 | 2004-05-20 | Kenji Morishima | Eye drops |
| JP2006510657A (ja) * | 2002-12-06 | 2006-03-30 | アライバ ファーマシューティカルズ，インコーポレイティド | 中耳炎の処置のための方法および組成物 |
| EP1651210A1 (en) * | 2003-07-31 | 2006-05-03 | Pharmacia & Upjohn Company LLC | Dispersible formulation of an anti-inflammatory agent |
| DE10347994A1 (de) * | 2003-10-15 | 2005-06-16 | Pari GmbH Spezialisten für effektive Inhalation | Wässrige Aerosol-Zubereitung |
| GB0413954D0 (en) * | 2004-06-22 | 2004-07-28 | Altunkaya Ali | Compositions for topical treatment |
| US20090111780A1 (en) | 2007-10-31 | 2009-04-30 | Everett Laboratories, Inc. | Compositions and methods for treatment of ear canal infection and inflammation |
| WO2010011466A2 (en) * | 2008-06-27 | 2010-01-28 | Otonomy, Inc. | Controlled-release cns modulating compositions and methods for the treatment of otic disorders |
| US8318817B2 (en) * | 2008-07-21 | 2012-11-27 | Otonomy, Inc. | Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
-
2010
- 2010-03-01 PL PL10155005T patent/PL2366408T3/pl unknown
- 2010-03-01 EP EP10155005A patent/EP2366408B1/en active Active
- 2010-03-01 DK DK10155005.1T patent/DK2366408T3/da active
- 2010-03-01 ES ES10155005T patent/ES2391721T3/es active Active
- 2010-03-24 US US12/730,681 patent/US8932610B2/en active Active
-
2011
- 2011-02-28 MX MX2012010009A patent/MX2012010009A/es active IP Right Grant
- 2011-02-28 CA CA2790652A patent/CA2790652C/en active Active
- 2011-02-28 KR KR1020127025195A patent/KR101777157B1/ko active IP Right Grant
- 2011-02-28 BR BR112012021638-4A patent/BR112012021638B1/pt active IP Right Grant
- 2011-02-28 WO PCT/EP2011/052939 patent/WO2011107436A2/en active Application Filing
- 2011-02-28 RU RU2012141641/15A patent/RU2549465C2/ru active
- 2011-02-28 AU AU2011223095A patent/AU2011223095B2/en active Active
- 2011-02-28 CN CN201180009966.6A patent/CN102811741B/zh active Active
- 2011-02-28 JP JP2012555383A patent/JP5744922B2/ja active Active
- 2011-03-01 AR ARP110100633A patent/AR080368A1/es unknown
-
2012
- 2012-03-14 HK HK12102610.2A patent/HK1162145A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP5744922B2 (ja) | 2015-07-08 |
| PL2366408T3 (pl) | 2013-01-31 |
| CA2790652A1 (en) | 2011-09-09 |
| AR080368A1 (es) | 2012-04-04 |
| BR112012021638A2 (pt) | 2017-08-08 |
| CA2790652C (en) | 2016-11-08 |
| RU2012141641A (ru) | 2014-04-10 |
| DK2366408T3 (da) | 2012-10-22 |
| EP2366408B1 (en) | 2012-07-18 |
| EP2366408A1 (en) | 2011-09-21 |
| BR112012021638B1 (pt) | 2020-10-27 |
| WO2011107436A3 (en) | 2011-11-10 |
| KR20130026430A (ko) | 2013-03-13 |
| KR101777157B1 (ko) | 2017-09-26 |
| AU2011223095B2 (en) | 2015-09-17 |
| CN102811741A (zh) | 2012-12-05 |
| RU2549465C2 (ru) | 2015-04-27 |
| AU2011223095A1 (en) | 2012-08-16 |
| US8932610B2 (en) | 2015-01-13 |
| JP2013521245A (ja) | 2013-06-10 |
| US20110212932A1 (en) | 2011-09-01 |
| WO2011107436A2 (en) | 2011-09-09 |
| ES2391721T3 (es) | 2012-11-29 |
| CN102811741B (zh) | 2015-05-13 |
| MX2012010009A (es) | 2012-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1162145A1 (en) | Aqueous clear solutions of fluocinolone acetonide for treatment of otic inflammation | |
| HK1245130A1 (zh) | 酶組合物及其用於創傷愈合的用途 | |
| EP2916876A4 (en) | METHOD AND COMPOSITIONS FOR WOUND HEALING | |
| EP2680923A4 (en) | TISSUE TREATMENT AND MONITORING THROUGH THE USE OF ENERGY | |
| EP2670434A4 (en) | TREATMENT OF TAUOPATHIA | |
| LT2683731T (lt) | C4-monometiltriterpenoido dariniai ir jų panaudojimo būdai | |
| HK1199015A1 (en) | Treatment of inflammation | |
| EP2704678A4 (en) | ABSORBENT BUFFER | |
| EP2793780A4 (en) | METHOD FOR PRODUCING A TAMPON | |
| EP2696874A4 (en) | COMPOSITIONS AND METHODS USED TO TREAT NASAL CONDITIONS | |
| SG11201500615WA (en) | Method of promoting wound healing | |
| EP2688595A4 (en) | LIN28 REGULATION OF LET-7 BIOGENESIS | |
| EP2574172A4 (en) | MATERIALS AND METHOD FOR TREATING INFLAMMATION | |
| EP2699198A4 (en) | BIODEGRADABLE MEDICAL DEVICES AND METHOD FOR CONTROLLING DEGRADATION OF SAID BIODEGRADABLE MEDICAL DEVICES | |
| EP2706845A4 (en) | ANTIMICROBIAL SOLID MATERIAL AND METHODS OF MAKING AND USING SAME | |
| PL2763769T3 (pl) | Obróbka roztworów wodnych | |
| EP2744530A4 (en) | GERILLTE ACTIVE AGGREGATING MEDICAL DEVICES AND MANUFACTURING METHOD THEREFOR | |
| HK1197185A1 (en) | Methods and compositions for treatment of epithelial wounds | |
| EP2797793A4 (en) | SYSTEM AND METHOD FOR CONSCIENTIZING CLOSE OBJECTS | |
| GB201100651D0 (en) | Treatment of inflammation | |
| AU2011902491A0 (en) | Prevention and treatment of haematological conditions | |
| AU2012902706A0 (en) | Prevention and treatment of haematological conditions | |
| AU2011902394A0 (en) | Prevention and treatment of acute inflammatory conditions | |
| AU2011905331A0 (en) | Treatment of seborrhoea | |
| GB201121044D0 (en) | Treatment of solutions |